Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Varun Saxena

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 23, 2019
Prevalence of Spontaneous Clearance of Hepatitis C Virus Infection Doubled From 1998 to 2017Suk Seo, Michael J Silverberg, Leo B Hurley, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2025
Predicting Metabolic Dysfunction Associated Steatotic Liver Disease Risk Using Patient-Derived Induced Pluripotent Stem CellsYuanyuan Qin, Parth Chhetri, Elizabeth Theusch, et al.
Open Forum Infectious Diseases|March 5, 2020
Life Expectancy of Insured People With and Without Hepatitis C Virus Infection, 2007-2017Julia L Marcus, Leo B Hurley, Scott Chamberland, et al.
Stem Cells Translational Medicine|January 9, 2026
Predicting metabolic dysfunction-associated steatotic liver disease risk using patient-derived induced pluripotent stem cellsYuanyuan Qin, Parth Chhetri, Elizabeth Theusch, et al.
International Journal of STD & AIDS|May 4, 2019
Hepatitis C treatment uptake and response among human immunodeficiency virus/hepatitis C virus-coinfected patients in a large integrated healthcare systemJennifer O Lam, Leo B Hurley, Scott Chamberland, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 15, 2018
No Difference in Effectiveness of 8 vs 12 Weeks of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C in Black PatientsJulia L Marcus, Leo B Hurley, Scott Chamberland, et al.
Public Health Reports (Washington, D.C. : 1974)|May 12, 2018
Disparities in Initiation of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection in an Insured PopulationJulia L Marcus, Leo B Hurley, Scott Chamberland, et al.
Hepatology (Baltimore, Md.)|May 16, 2017
Safety and efficacy of current direct-acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: Results from the HCV-TARGET studyVarun Saxena, Vandana Khungar, Elizabeth C Verna, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 23, 2019
Prevalence of Spontaneous Clearance of Hepatitis C Virus Infection Doubled From 1998 to 2017Suk Seo, Michael J Silverberg, Leo B Hurley, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2025
Predicting Metabolic Dysfunction Associated Steatotic Liver Disease Risk Using Patient-Derived Induced Pluripotent Stem CellsYuanyuan Qin, Parth Chhetri, Elizabeth Theusch, et al.
Open Forum Infectious Diseases|March 5, 2020
Life Expectancy of Insured People With and Without Hepatitis C Virus Infection, 2007-2017Julia L Marcus, Leo B Hurley, Scott Chamberland, et al.
Stem Cells Translational Medicine|January 9, 2026
Predicting metabolic dysfunction-associated steatotic liver disease risk using patient-derived induced pluripotent stem cellsYuanyuan Qin, Parth Chhetri, Elizabeth Theusch, et al.
International Journal of STD & AIDS|May 4, 2019
Hepatitis C treatment uptake and response among human immunodeficiency virus/hepatitis C virus-coinfected patients in a large integrated healthcare systemJennifer O Lam, Leo B Hurley, Scott Chamberland, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 15, 2018
No Difference in Effectiveness of 8 vs 12 Weeks of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C in Black PatientsJulia L Marcus, Leo B Hurley, Scott Chamberland, et al.
Public Health Reports (Washington, D.C. : 1974)|May 12, 2018
Disparities in Initiation of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection in an Insured PopulationJulia L Marcus, Leo B Hurley, Scott Chamberland, et al.
Hepatology (Baltimore, Md.)|May 16, 2017
Safety and efficacy of current direct-acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: Results from the HCV-TARGET studyVarun Saxena, Vandana Khungar, Elizabeth C Verna, et al.
Pageof 5